FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2792300635> ?p ?o ?g. }

• W2792300635 endingPage "2955" @default.
• W2792300635 startingPage "2942" @default.
• W2792300635 abstract "It is recommended to perform atrial fibrillation ablation with continuous anticoagulation. Continuous apixaban has not been tested. We compared continuous apixaban (5 mg b.i.d.) to vitamin K antagonists (VKA, international normalized ratio 2–3) in atrial fibrillation patients at risk of stroke a prospective, open, multi-centre study with blinded outcome assessment. Primary outcome was a composite of death, stroke, or bleeding (Bleeding Academic Research Consortium 2–5). A high-resolution brain magnetic resonance imaging (MRI) sub-study quantified acute brain lesions. Cognitive function was assessed by Montreal Cognitive Assessment (MoCA) at baseline and at end of follow-up. Overall, 674 patients (median age 64 years, 33% female, 42% non-paroxysmal atrial fibrillation, 49 sites) were randomized; 633 received study drug and underwent ablation; 335 undertook MRI (25 sites, 323 analysable scans). The primary outcome was observed in 22/318 patients randomized to apixaban, and in 23/315 randomized to VKA {difference −0.38% [90% confidence interval (CI) −4.0%, 3.3%], non-inferiority P = 0.0002 at the pre-specified absolute margin of 0.075}, including 2 (0.3%) deaths, 2 (0.3%) strokes, and 24 (3.8%) ISTH major bleeds. Acute small brain lesions were found in a similar number of patients in each arm [apixaban 44/162 (27.2%); VKA 40/161 (24.8%); P = 0.64]. Cognitive function increased at the end of follow-up (median 1 MoCA unit; P = 0.005) without differences between study groups. Continuous apixaban is safe and effective in patients undergoing atrial fibrillation ablation at risk of stroke with respect to bleeding, stroke, and cognitive function. Further research is needed to reduce ablation-related acute brain lesions." @default.
• W2792300635 created "2018-03-29" @default.
• W2792300635 creator A5004448192 @default.
• W2792300635 creator A5005773814 @default.
• W2792300635 creator A5006122223 @default.
• W2792300635 creator A5006938674 @default.
• W2792300635 creator A5007975488 @default.
• W2792300635 creator A5007982457 @default.
• W2792300635 creator A5009363935 @default.
• W2792300635 creator A5017865820 @default.
• W2792300635 creator A5020026322 @default.
• W2792300635 creator A5022770657 @default.
• W2792300635 creator A5023346746 @default.
• W2792300635 creator A5026938977 @default.
• W2792300635 creator A5037739178 @default.
• W2792300635 creator A5041511821 @default.
• W2792300635 creator A5043730018 @default.
• W2792300635 creator A5046773983 @default.
• W2792300635 creator A5047325459 @default.
• W2792300635 creator A5048670406 @default.
• W2792300635 creator A5051559983 @default.
• W2792300635 creator A5053215060 @default.
• W2792300635 creator A5057565477 @default.
• W2792300635 creator A5058680940 @default.
• W2792300635 creator A5070387023 @default.
• W2792300635 creator A5076223123 @default.
• W2792300635 creator A5079597692 @default.
• W2792300635 date "2018-03-20" @default.
• W2792300635 modified "2023-10-16" @default.
• W2792300635 title "Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation" @default.
• W2792300635 cites W1583406651 @default.
• W2792300635 cites W1586488555 @default.
• W2792300635 cites W1966769180 @default.
• W2792300635 cites W1968678408 @default.
• W2792300635 cites W1998448195 @default.
• W2792300635 cites W2108168179 @default.
• W2792300635 cites W2113377180 @default.
• W2792300635 cites W2120775803 @default.
• W2792300635 cites W2122779695 @default.
• W2792300635 cites W2133698282 @default.
• W2792300635 cites W2149897387 @default.
• W2792300635 cites W2151707313 @default.
• W2792300635 cites W2153858333 @default.
• W2792300635 cites W2162508946 @default.
• W2792300635 cites W2163415952 @default.
• W2792300635 cites W2164489173 @default.
• W2792300635 cites W2164593641 @default.
• W2792300635 cites W2254541694 @default.
• W2792300635 cites W2301813342 @default.
• W2792300635 cites W2333001326 @default.
• W2792300635 cites W2527872858 @default.
• W2792300635 cites W2595627091 @default.
• W2792300635 cites W2599983821 @default.
• W2792300635 cites W2612100421 @default.
• W2792300635 cites W2774556389 @default.
• W2792300635 cites W2989714602 @default.
• W2792300635 cites W3004050106 @default.
• W2792300635 doi "https://doi.org/10.1093/eurheartj/ehy176" @default.
• W2792300635 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6110196" @default.
• W2792300635 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29579168" @default.
• W2792300635 hasPublicationYear "2018" @default.
• W2792300635 type Work @default.
• W2792300635 sameAs 2792300635 @default.
• W2792300635 citedByCount "160" @default.
• W2792300635 countsByYear W27923006352018 @default.
• W2792300635 countsByYear W27923006352019 @default.
• W2792300635 countsByYear W27923006352020 @default.
• W2792300635 countsByYear W27923006352021 @default.
• W2792300635 countsByYear W27923006352022 @default.
• W2792300635 countsByYear W27923006352023 @default.
• W2792300635 crossrefType "journal-article" @default.
• W2792300635 hasAuthorship W2792300635A5004448192 @default.
• W2792300635 hasAuthorship W2792300635A5005773814 @default.
• W2792300635 hasAuthorship W2792300635A5006122223 @default.
• W2792300635 hasAuthorship W2792300635A5006938674 @default.
• W2792300635 hasAuthorship W2792300635A5007975488 @default.
• W2792300635 hasAuthorship W2792300635A5007982457 @default.
• W2792300635 hasAuthorship W2792300635A5009363935 @default.
• W2792300635 hasAuthorship W2792300635A5017865820 @default.
• W2792300635 hasAuthorship W2792300635A5020026322 @default.
• W2792300635 hasAuthorship W2792300635A5022770657 @default.
• W2792300635 hasAuthorship W2792300635A5023346746 @default.
• W2792300635 hasAuthorship W2792300635A5026938977 @default.
• W2792300635 hasAuthorship W2792300635A5037739178 @default.
• W2792300635 hasAuthorship W2792300635A5041511821 @default.
• W2792300635 hasAuthorship W2792300635A5043730018 @default.
• W2792300635 hasAuthorship W2792300635A5046773983 @default.
• W2792300635 hasAuthorship W2792300635A5047325459 @default.
• W2792300635 hasAuthorship W2792300635A5048670406 @default.
• W2792300635 hasAuthorship W2792300635A5051559983 @default.
• W2792300635 hasAuthorship W2792300635A5053215060 @default.
• W2792300635 hasAuthorship W2792300635A5057565477 @default.
• W2792300635 hasAuthorship W2792300635A5058680940 @default.
• W2792300635 hasAuthorship W2792300635A5070387023 @default.
• W2792300635 hasAuthorship W2792300635A5076223123 @default.
• W2792300635 hasAuthorship W2792300635A5079597692 @default.
• W2792300635 hasBestOaLocation W27923006351 @default.
• W2792300635 hasConcept C126322002 @default.

• next